Surong Fang

536 total citations
23 papers, 412 citations indexed

About

Surong Fang is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Surong Fang has authored 23 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Surong Fang's work include MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Surong Fang is often cited by papers focused on MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Surong Fang collaborates with scholars based in China, Australia and United States. Surong Fang's co-authors include Wei Gu, Zhenhua Yang, Yan Tan, Yingying Qian, Wei Gu, Liang Ye, Hai Zhong, Yubao Chen, Mao Shan and Yuan Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Letters.

In The Last Decade

Surong Fang

22 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Surong Fang China 11 236 223 95 83 46 23 412
Ming Ma China 13 289 1.2× 140 0.6× 117 1.2× 123 1.5× 66 1.4× 56 490
Hang Lv China 15 249 1.1× 152 0.7× 126 1.3× 132 1.6× 84 1.8× 34 505
Agnieszka Bielska Poland 10 223 0.9× 187 0.8× 36 0.4× 92 1.1× 30 0.7× 14 389
Ailing Zhong China 13 192 0.8× 104 0.5× 124 1.3× 59 0.7× 42 0.9× 29 355
Yawei Shi China 14 203 0.9× 172 0.8× 149 1.6× 109 1.3× 49 1.1× 26 457
Guifang Lu China 14 405 1.7× 325 1.5× 46 0.5× 67 0.8× 83 1.8× 23 595
Yunchang Yuan China 14 419 1.8× 283 1.3× 58 0.6× 78 0.9× 68 1.5× 28 607
Carina Pereira Portugal 13 163 0.7× 134 0.6× 115 1.2× 63 0.8× 106 2.3× 31 453
Changyuan Wei China 12 154 0.7× 165 0.7× 151 1.6× 63 0.8× 92 2.0× 24 436
Peide Bai China 12 265 1.1× 237 1.1× 104 1.1× 151 1.8× 34 0.7× 31 499

Countries citing papers authored by Surong Fang

Since Specialization
Citations

This map shows the geographic impact of Surong Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surong Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surong Fang more than expected).

Fields of papers citing papers by Surong Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surong Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surong Fang. The network helps show where Surong Fang may publish in the future.

Co-authorship network of co-authors of Surong Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Surong Fang. A scholar is included among the top collaborators of Surong Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surong Fang. Surong Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Feifei, Juan Chen, Yuan Yuan, et al.. (2024). Circ_100549 promotes tumor progression in lung adenocarcinoma through upregulation of BIRC6. Histochemistry and Cell Biology. 161(6). 493–506. 1 indexed citations
2.
Liu, Wenfei, Surong Fang, Zhenhua Yang, et al.. (2023). ITGA9-AS1 up-regulates ITGA9 by targeting miR-4765 and recruiting HNRNPU to affect the proliferation and apoptosis of non-small cell lung cancer cells. Cellular and Molecular Biology. 69(14). 22–28. 2 indexed citations
3.
Zhao, Yueming, Danyang Zhou, Yuan Yuan, et al.. (2023). MAPKAPK5-AS1/miR-515-5p/CAB39 Axis Contributes to Non-small Cell Lung Cancer Cell Proliferation and Migration. Molecular Biotechnology. 65(11). 1887–1897. 5 indexed citations
4.
Yuan, Yuan, et al.. (2023). Identification of an Exosome-relevant SNHG6-hsa-miR-429-CHRDL1/CCNA2 Axis for Lung Adenocarcinoma PrognosisEvaluation. Current Medicinal Chemistry. 31(28). 4549–4561. 4 indexed citations
5.
Chen, Jing, Yuan Yuan, Surong Fang, et al.. (2021). Exosome-mediated transfer of SNHG7 enhances docetaxel resistance in lung adenocarcinoma. Cancer Letters. 526. 142–154. 59 indexed citations
6.
Xu, Chenyu, Mao Shan, Ying Shi, et al.. (2020). Lipoprotein-associated phospholipase A2 predicted cardiovascular disease in obstructive sleep apnea syndrome. Respiratory Medicine. 163. 105881–105881. 6 indexed citations
7.
Zhong, Hai, Liang Ye, Qian Li, et al.. (2020). Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis. BMC Pulmonary Medicine. 20(1). 96–96. 29 indexed citations
8.
Fang, Surong, et al.. (2020). The Molecular Mechanism of Metabolic Remodeling in Lung Cancer. Journal of Cancer. 11(6). 1403–1411. 37 indexed citations
9.
10.
Ye, Liang, Mao Shan, Surong Fang, et al.. (2019). Increased Serum Romo1 Was Correlated with Lung Function, Inflammation, and Oxidative Stress in Chronic Obstructive Pulmonary Disease. Inflammation. 42(5). 1555–1560. 16 indexed citations
11.
Fang, Surong, Yubao Chen, Zhenhua Yang, et al.. (2019). Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway. Lipids in Health and Disease. 18(1). 118–118. 53 indexed citations
12.
Yang, Zhenhua, et al.. (2018). Clinical Value of 99mTc-3PRGD2 Molecular Image in Evaluating Effect of Recombinant Endostatin. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Ye, Liang, Yingying Qian, Qian Li, et al.. (2018). Serum Romo1 is significantly associated with disease severity in patients with obstructive sleep apnea syndrome. Sleep And Breathing. 22(3). 743–748. 9 indexed citations
14.
Zhong, Hai, Yingying Qian, Surong Fang, et al.. (2018). Prognostic Value of Plasma Fibrinogen in Lung Cancer Patients: A Meta-Analysis. Journal of Cancer. 9(21). 3904–3911. 27 indexed citations
15.
Zhong, Hai, et al.. (2017). HE4 expression in lung cancer, a meta-analysis. Clinica Chimica Acta. 470. 109–114. 21 indexed citations
17.
Yang, Zhenhua, et al.. (2015). Modulation of NF-κB/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin. PLoS ONE. 10(3). e0121547–e0121547. 67 indexed citations
18.
Zhang, Xunlei, Jianhong Wang, Surong Fang, et al.. (2015). Increased risk of developing lung cancer in Asian patients carrying the TERT rs2736098 G>A polymorphism: evidence from 3,354 cases and 3,518 controls. OncoTargets and Therapy. 8. 2757–2757. 6 indexed citations
19.
Fang, Surong, et al.. (2015). Proanthocyanidin from Grape Seed Extract Inhibits Airway Inflammation and Remodeling in a Murine Model of Chronic Asthma. Natural Product Communications. 10(2). 257–62. 17 indexed citations
20.
Shi, Ying, et al.. (2014). A Liver-X-Receptor Ligand, T0901317, Attenuates IgE Production and Airway Remodeling in Chronic Asthma Model of Mice. PLoS ONE. 9(3). e92668–e92668. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026